Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

Circulation

Volumn 94, Issue 11, 1996, Pages 2756-2767

  Diet, Frank ^a   Pratt, Richard E ^a,b   Berry, Gerald J ^a   Momose, Naoko ^a   Gibbons, Gary H ^a   Dzau, Victor J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

angiotensin; endothelium; immunohistochemistry; lipoproteins; vasculature

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE CLASSIFICATION; ENZYME ASSAY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TISSUE DISTRIBUTION;

EID: 0029823037     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2756     Document Type: Article

References (59)

1. Ehlers MRW, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry. 1989;28: 5311-5318.
2. Caldwell PR, Seegal BC, Hsu KC. Angiotensin-converting enzyme: vascular endothelial localization. Science. 1976;191:1050-1051.
3. Rakugi H, Duk-Kyung K, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J Clin Invest. 1994;93: 339-346.
4. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 1994;94:978-984.
5. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
6. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1419-1424.
7. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia: autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest. 1992;90:456-461.
8. Naftilan AJ, Pratt RE, Eldridge CS, Lin HL, Dzau VJ. Angiotensin II induced c-fos expression in smooth muscle via transcriptional control. Hypertension. 1989;13:706-711.
9. Itoh H, Pratt RE, Gibbons G, Dzau VJ. Multiple autocrine growth factors mutate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
10. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-456.
11. Powell JS, Clozel J-P, Muller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989; 245:186-188.
12. Osterrieder W, Muller RK, Powell JS, Clozel JP, Hefti F, Baumgartner HR. Role of angiotensin II in injury-induced neointima formation in rats. Hypertension. 1991;18(suppl IV):II-60-II-64.
13. Schuh JR, Blehm DJ, Frierdich GE, McMahon EG, Blaine EH. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest. 1993;91: 1453-1458.
14. Chobanian AV, Haudenschild CC Nickerson C, Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 1990;15:327-331.
15. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol. 1990;15(suppl 5):S65-S72.
16. Gräfe M, Auch-Schwelk W, Graf K, Hertel H, Hoffmann R, Bartsch P, Regitz-Zagrosek V, Hildebrandt A, Fleck E. Circulation. 1993; 88(suppl 1):I-316. Abstract.
17. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994,74:1141-1148.
18. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II: evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation. 1993;87:1969-1973.
19. van Leeuwen RTJ, Kol A, Andreotti F, Kluft C, Maseri A, Sperti G. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation. 1994;90:362-368.
20. 2+ concentrations in essential hypertension. Hypertension. 1993;22:853-862.
21. Linz W, Wiemer G, Scholkens BA. Contribution of brady kinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol. 1993; 22(suppl 9):S1-S8.
22. Pfeffer MA, Braunwald E, Moye L, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas G, Packer M, Rouleau J, Rouleau J, Rutherford J. Wertheimer JH, Hawkins CM. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669-677.
23. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
24. Kaplan HR, Taylor DC, Olson SC, Andrews LK. Quinapril: a preclinical review of the pharmacology, pharmacokinetics, and toxicology. Angiology. 1989;40:335-350.
25. Weishaar RE, Panek RL, Major TC, Simmerman J, Rapundalo ST, Taylor DC. Evidence for a functional tissue renin-angiotensin system in the rat mesenteric vasculature and its involvement in regulating blood pressure. J Pharmacol Exp Ther. 1991;256:568-574.
26. Rakugi H, Wang DS, Dzau VJ, Pratt RE. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation. 1994;90:449-455.
27. Gown AM, Tsukada T, ROSS R. Human atherosclerosis, II: immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 1986;125:191-207.
28. Danilov SM, Allikmets EY, Sakharov IY, Dukhanina EA, Trakht IN. Monoclonal antibody to human lung angiotensin-converting enzyme. Biotechnol Appl Biochem. 1987;9:319-322.
29. Danilov SM, Faerman AI, Printseva OY, Martynov AV, Sakharov IY, Trakht IN. Immunohistochemical study of angiotensin-converting enzyme in human tissues using monoclonal antibodies. Histochemistry. 1987;87:487-490.
30. Danilov SM, Chumacbenko PV, Andreeva YV, Printseva OY, Lacis RV. Angiotensin converting enzyme expression in the inflammation zone of human myocardial infarction and rat model of skin injury. J Hypertens. 1993;11(suppl 5):S232-S233.
31. Cheung HS, Cushman DW. Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrop's jararaca. Biochim Biophys Acta. 1973;293:451-463.
32. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 1982;42:1530-1536.
33. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions. Council of Atherosclerosis, American Heart Association. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwanz CJ, Wagner WD, Wissler RW. Circulation. 1995;92:1355-1374.
34. Fuster V. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994,90:2126-2146.
35. Rogerson FM, Chai SY, Schlawe I, Murray WK, Marley PD, Mendelsohn FA. Presence of angiotensin converting enzyme in the adventitia of large blood vessels. J Hypertens. 1992;10:615-620.
36. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, Dzau VJ. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res. 1993;72: 312-318.
37. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression T-lymphocytes. Biochem J. 1993;290:33-40.
38. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Soubrier F, Alhenc-Gelas F. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.
39. Unger T, Ganten D, Lang RE, Scholkens BA. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneous hypertensive rats. J Cardiovasc Pharmacol. 1985;7:36-41.
40. Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine: a paradigm shift? Circulation. 1994;89:493-498.
41. Hahn AWA, Jonas U, Buhler FR, Resink TJ. Activation of human peripheral monocytes by angiotensin II. FEBS Lett. 1994;347: 178-180.
42. Weinstock JV, Blum AM, Kassab JT. Angiotensin II is chemotactic for a T-cell subset which can express migration inhibition factor activity in murine schistosomiasis mansoni. Cell Immunol. 1987; 107:180-187.
43. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991;9:17-22.
44. Bell L, Madri JA. Rapid communicational influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol. 1990;137:7-12.
45. Gadiparthi NR, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res. 1992;70:593-599.
46. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest. 1982;47:412-426.
47. Mügge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated super-oxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 1991;69:1293-1300.
48. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993;92:1866-1874.
49. Farhy RD, Ho K-L, Carretero OA, Scicli AG. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun. 1992;182:283-288.
50. Ryu JH, Vuk-Pavlovic Z, Rohrbach MS. Monocyte heterogeneity in angiotensin-converting enzyme induction mediated by autologous T lymphocytes. Clin Exp Immunol. 1992;88:288-294.
51. Rohrbach MS, Conrad AK. Comparison of the T lymphocyte-dependent induction of angiotensin-converting enzyme and leucine amino-peptidase in cultured human monocytes. Clin Exp Immunol. 1991; 83:510-515.
52. Weinstock JV, Boros DL. Alteration of granuloma angiotensin I-converting enzyme activity by regulatory T lymphocytes in murine schistosomiasis. Infect Immun. 1982;35:465-470.
53. Weinstock JV, Blum AM. Isolated liver granulomas of murine schistosoma mansoni contain components of the angiotensin System. J Immunol. 1983;131:2529-2532.
54. Fishel R, Shai S, Nore K, Bernstein K, Berk B. Endothelial cell angiotensin converting enzyme expression is upregulated by fluid shear stress. FASEB J. 1991;5:1-85. Abstract.
55. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries: association of acidic FGF with plaque microvessels and macrophages. J Clin Invest. 1993;92:2408-2418.
56. Shimokawa H, Tomoike H, Nabeyama S, Yamamoto H, Araki H, Nakamura M. Coronary artery spasm induced in atherosclerotic miniature swine. Science. 1983;221:560-561.
57. Falk E. Why do plaques rupture? Circulation. 1992;86(suppl III):III-30-111-42.
58. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
59. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerosis plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.